Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IVIG in Elderly COVID-19 Patients with Severe Respiratory Failure
NCT04403269Phase 2Unknown
- Sponsor
- Centre Hospitalier de Versailles
- Start
- May 2020
- Primary completion
- May 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of intravenous immunoglobulin G in coronavirus disease 2019 (COVID-19), acute respiratory failure (ARF), sponsored by Centre Hospitalier de Versailles. Status: unknown.
02
Drugs
intravenous immunoglobulin G
03
Conditions
coronavirus disease 2019 (COVID-19)acute respiratory failure (ARF)
Beyond the preview
Go deeper on NCT04403269.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04403269.